JP2025505696A5 - - Google Patents
Info
- Publication number
- JP2025505696A5 JP2025505696A5 JP2024547315A JP2024547315A JP2025505696A5 JP 2025505696 A5 JP2025505696 A5 JP 2025505696A5 JP 2024547315 A JP2024547315 A JP 2024547315A JP 2024547315 A JP2024547315 A JP 2024547315A JP 2025505696 A5 JP2025505696 A5 JP 2025505696A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence number
- optionally
- washing buffer
- protein
- buffer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263267810P | 2022-02-10 | 2022-02-10 | |
| US63/267,810 | 2022-02-10 | ||
| PCT/US2023/062322 WO2023154822A2 (en) | 2022-02-10 | 2023-02-09 | Methods of purifying a product |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025505696A JP2025505696A (ja) | 2025-02-28 |
| JP2025505696A5 true JP2025505696A5 (enExample) | 2026-02-12 |
Family
ID=87521638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547315A Pending JP2025505696A (ja) | 2022-02-10 | 2023-02-09 | 生産物の精製方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230250133A1 (enExample) |
| EP (1) | EP4476237A2 (enExample) |
| JP (1) | JP2025505696A (enExample) |
| KR (1) | KR20240142564A (enExample) |
| CN (1) | CN119032099A (enExample) |
| AU (1) | AU2023217074A1 (enExample) |
| CA (1) | CA3251000A1 (enExample) |
| IL (1) | IL314472A (enExample) |
| MX (1) | MX2024009755A (enExample) |
| WO (1) | WO2023154822A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015035342A2 (en) | 2013-09-08 | 2015-03-12 | Oligasis Llc | Factor viii zwitterionic polymer conjugates |
| AU2018250695A1 (en) | 2017-04-14 | 2019-11-07 | Kodiak Sciences Inc. | Complement factor D antagonist antibodies and conjugates thereof |
| US12071476B2 (en) | 2018-03-02 | 2024-08-27 | Kodiak Sciences Inc. | IL-6 antibodies and fusion constructs and conjugates thereof |
| AU2020364071A1 (en) | 2019-10-10 | 2022-05-26 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
| WO2025073922A1 (en) * | 2023-10-04 | 2025-04-10 | Sartorius Bia Separations D.O.O. | Enhanced chromatographic separations of components in a mixture by employing chaotropic elution |
| WO2025184423A1 (en) * | 2024-02-29 | 2025-09-04 | Kodiak Sciences Inc. | Cell-surface-targeting-domain-polymer-payload conjugate |
| US20260092109A1 (en) * | 2024-09-06 | 2026-04-02 | Eyebiotech Limited | Multivalent fzd4, wnt co-receptor, and vegf receptor molecules and uses thereof |
| US20260092125A1 (en) * | 2024-09-06 | 2026-04-02 | Eyebiotech Limited | Multivalent fzd4, wnt co-receptor, and vegf binding molecules and uses thereof |
| WO2026075981A1 (en) * | 2024-10-01 | 2026-04-09 | Regeneron Pharmaceuticals, Inc. | Methods of analyzing heterodimeric proteins |
| CN119524125A (zh) * | 2024-11-28 | 2025-02-28 | 北海康成(苏州)生物制药有限公司 | 一种欧莫扑拜单抗原液的生产方法及欧莫扑拜单抗原液 |
| CN119454939A (zh) * | 2024-11-28 | 2025-02-18 | 北海康成(苏州)生物制药有限公司 | 一种欧莫扑拜单抗原液及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7045314B2 (en) * | 2000-04-04 | 2006-05-16 | Baxter International Inc. | Method for the production of bacterial toxins |
| RU2011137030A (ru) * | 2009-03-11 | 2013-04-20 | УАЙТ ЭлЭлСи | Способы очистки малых модулярных иммунофармацевтических белков |
| AU2012328880B2 (en) * | 2011-10-24 | 2017-02-23 | Halozyme, Inc. | Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof |
| ES2895752T3 (es) * | 2014-01-03 | 2022-02-22 | Hoffmann La Roche | Anticuerpos biespecíficos anti-hapteno/anti-receptor de la barrera hematoencefálica, complejos de los mismos y su uso como lanzaderas a través de la barrera hematoencefálica |
| BR112016014969A2 (pt) * | 2014-01-15 | 2018-01-23 | Hoffmann La Roche | polipeptídeo, formulação farmacêutica e uso de um polipeptídeo |
| EP3054007A1 (en) * | 2015-02-09 | 2016-08-10 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step |
| JP6959912B2 (ja) * | 2015-09-23 | 2021-11-05 | ジェネンテック， インコーポレイテッド | 抗ｖｅｇｆ抗体の最適化変異体 |
| KR20250057128A (ko) * | 2015-12-30 | 2025-04-28 | 코디악 사이언시스 인코포레이티드 | 항체 및 이의 접합체 |
| US12071476B2 (en) * | 2018-03-02 | 2024-08-27 | Kodiak Sciences Inc. | IL-6 antibodies and fusion constructs and conjugates thereof |
| US20210254073A1 (en) * | 2020-02-04 | 2021-08-19 | Cornell University | Methods for capture and analysis of macromolecular complexes |
-
2023
- 2023-02-09 CA CA3251000A patent/CA3251000A1/en active Pending
- 2023-02-09 US US18/166,755 patent/US20230250133A1/en active Pending
- 2023-02-09 IL IL314472A patent/IL314472A/en unknown
- 2023-02-09 MX MX2024009755A patent/MX2024009755A/es unknown
- 2023-02-09 JP JP2024547315A patent/JP2025505696A/ja active Pending
- 2023-02-09 WO PCT/US2023/062322 patent/WO2023154822A2/en not_active Ceased
- 2023-02-09 EP EP23753671.9A patent/EP4476237A2/en active Pending
- 2023-02-09 AU AU2023217074A patent/AU2023217074A1/en active Pending
- 2023-02-09 KR KR1020247030267A patent/KR20240142564A/ko active Pending
- 2023-02-09 CN CN202380033420.7A patent/CN119032099A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101921767B1 (ko) | 단백질 정제 | |
| AU2014300486B2 (en) | Purification process for monoclonal antibodies | |
| RU2558367C2 (ru) | Способ очистки полипептидных растворов | |
| JP7187436B2 (ja) | アフィニティークロマトグラフィー洗浄バッファー | |
| JP2024059888A5 (enExample) | ||
| JP2012507557A5 (enExample) | ||
| JP2016523812A (ja) | タンパク質のピログルタミン酸形成を増加させるための方法 | |
| RU2011137030A (ru) | Способы очистки малых модулярных иммунофармацевтических белков | |
| JPH01277488A (ja) | 新規生理活性ポリペプチド | |
| CN113416243B (zh) | 一种纯化抗体的方法 | |
| JP2022518282A5 (enExample) | ||
| TWI911155B (zh) | 藉由多肽鏈交換活化之治療性多特異性多肽 | |
| US20230143163A1 (en) | Protein a chromatography purification of an antibody | |
| CN113166200A (zh) | 一种提高蛋白a层析法去除聚集体的方法 | |
| JP2025509722A5 (enExample) | ||
| AU2013314264B2 (en) | Method for the production of polypeptides in the periplasm of prokaryotic cells | |
| JP2024513835A5 (enExample) | ||
| JP2022554283A5 (enExample) | ||
| CN114539416A (zh) | 一种双特异性抗体的层析纯化工艺 | |
| EP4696709A1 (en) | Variants of etanercept and related processes | |
| CN103864916B (zh) | 人胸腺肽β4三倍体蛋白、编码基因及其分离纯化方法 | |
| CN117866103A (zh) | 一种抗破伤风双特异性抗体及其制备方法与应用 | |
| WO2016103139A1 (en) | Method for reduction of aggregates | |
| CN120965862A (zh) | 一种NbES9单域抗体、NbES9-TAT融合单域抗体及其用途 | |
| CN114621354A (zh) | Fab-白蛋白结合肽融合蛋白及其制备方法和应用 |